The FDA granted accelerated approval to Bristol-Myers’s skin-cancer treatment Opdivo, which uses the body’s immune system to fight tumors.
from WSJ.com: US Business http://ift.tt/1Hr8vH9
via IFTTT
from WSJ.com: US Business http://ift.tt/1Hr8vH9
via IFTTT
No comments:
Post a Comment